Jansen Superconducting

Founded in 2013 and headquartered in Cixi, China, Ningbo Jansen Superconducting Technologies Co. , Ltd. focuses on the production of core components for MRI systems. In December 2025, Jansen Superconducting raised CNY 778,873,600 in an IPO, selling 41,920,000 shares at CNY 18.

58 per share at Shanghai Stock Exchange, under the ticker "688805". Jansen Superconducting primarily focuses on the research, development, manufacturing, and sales of core components for medical magnetic resonance imaging (MRI) equipment. Their main product offerings include superconducting magnets, permanent magnets, and gradient coils, which are essential for the operation of MRI systems. These components are designed to enhance the imaging capabilities of MRI machines, making them more efficient and accessible for medical diagnostics.

The company targets hospitals and medical facilities as its primary clients, aiming to provide advanced technology that enables better health outcomes. Their products are distributed not only within China but also in international markets, including India and Italy, reflecting their strategy to establish a global footprint in the medical imaging sector. The company generates revenue through direct sales of its MRI core components to healthcare providers and institutions. The company engages in business transactions that typically involve B2B partnerships, where hospitals and medical centers purchase these essential components to integrate into their MRI systems.

Revenue is augmented through contract agreements for the supply of customized superconducting systems, such as the flagship "1. 5T liquid-helium-free superconducting magnet system," which has been recognized for its innovation within the industry. The pricing structure for these products is tailored to the specifications of the client’s needs, ensuring compatibility and performance efficiency, thereby fostering long-term relationships with clients who depend on reliable MRI technology for patient care.